NEW YORK (AP) - The U.S. National Cancer Institute said on Monday it halted a trial it was sponsoring of AstraZeneca PLC cancer drug Iressa because the medicine was not increasing patients' survival....More
Tuesday, April 19, 2005
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment